Since 2000, Innovaderm has conducted clinical studies on a vast range of dermatological conditions:
All phototypes in adults, adolescents, children and the elderly
USA
Canada
Europe
Oral, subcutaneous, injectable (including IV), topical and patch
New Chemical Entity (NCE), biologics, dermal fillers, natural health products, cannabinoid derivatives, etc.
Innovaderm conducts safety and efficacy studies in dermatology. Some involve systemic compounds while others involve topical compounds.